Bioaffinity Technologies, Inc. (BIAF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bioaffinity Technologies, Inc., a Delaware corporation, on July 30, 2026. The Company is listed on The Nasdaq Capital Market under the trading symbols BIAF (Common Stock) and BIAFW (Warrants). The report addresses a critical regulatory event regarding the Company's continued listing status.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the market price of the Company's securities, which closed at less than $1.00 per share for 30 consecutive business days ending July 29, 2026.
Material Changes and Events
- Nasdaq Non-Compliance Notice: On July 30, 2026, the Company received a Staff Determination from Nasdaq stating it failed to meet the Minimum Bid Price Requirement (Rule 5550(a)(2)) due to its stock price remaining below $1.00 from June 16, 2026, through July 29, 2026.
- Ineligibility for Standard Compliance Period: The Company is not eligible for the standard 180-calendar day compliance period because it executed a 1-for-30 reverse stock split on September 19, 2025, within the prior one-year period (Rule 5810(c)(3)(A)(iv)).
- Appeal Filing: The Company intends to submit an appeal to Nasdaq on August 6, 2026. This appeal will stay the delisting and suspension of securities pending the Panel's decision.
Outlook, Risks, and Management Commentary
Management intends to present its views and plans to regain compliance at the upcoming hearing. However, the filing explicitly states there can be no assurance that the Company will evidence compliance, that the Panel will grant an extension, or that the Company will successfully maintain its listing. The report includes forward-looking statements regarding the timing of the hearing and the Panel's decision, noting that actual timelines may differ from expectations and could be unfavorable to the Company.
Investor Verification Checklist
- Verify the status of the appeal scheduled for August 6, 2026, and the subsequent decision timeline from the Nasdaq Listing Qualifications Panel.
- Confirm the current trading price of BIAF to assess if it remains below the $1.00 threshold.
- Review the Company's specific plan to regain compliance with the Minimum Bid Price Requirement as presented in the appeal.
- Monitor for any further 8-K filings regarding the outcome of the appeal or potential delisting.